Sec Form 4 Filing - Pourhassan Nader @ CytoDyn Inc. - 2020-04-30

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Pourhassan Nader
2. Issuer Name and Ticker or Trading Symbol
CytoDyn Inc. [ CYDY]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
President & CEO
(Last) (First) (Middle)
1111 MAIN STREET, SUITE 660
3. Date of Earliest Transaction (MM/DD/YY)
04/30/2020
(Street)
VANCOUVER, WA98660
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 04/30/2020 M 200,000 A $ 0.9 517,417 D
Common Stock 04/30/2020 M 325,000 A $ 0.87 842,417 D
Common Stock 04/30/2020 M 152,000 A $ 0.75 994,417 D
Common Stock 04/30/2020 M 600,000 A $ 1.09 1,594,417 D
Common Stock 04/30/2020 M 199,800 A $ 0.57 1,794,217 D
Common Stock 04/30/2020 M 600,000 A $ 0.8 2,394,217 D
Common Stock 04/30/2020 M 116,550 A $ 0.49 2,510,767 D
Common Stock 04/30/2020 M 1,000,000 A $ 0.565 3,510,767 D
Common Stock 04/30/2020 M 187,817 A $ 0.39 3,698,584 D
Common Stock 04/30/2020 M 2,000,000 A $ 0.63 5,698,584 D
Common Stock 04/30/2020 S 2,219,837 D $ 3.5312 ( 1 ) 3,478,747 D
Common Stock 05/01/2020 S 1,399,685 D $ 3.2644 ( 2 ) 2,079,062 D
Common Stock 05/04/2020 M 30,933 A $ 0.39 2,109,995 D
Common Stock 05/04/2020 S 1,201,652 D $ 2.7904 ( 3 ) 908,343 D
Common Stock 15,570 I By Spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option $ 0.9 04/30/2020 M 150,000 06/30/2018 06/30/2025 Common Stock 150,000 $ 0 0 D
Employee Stock Option $ 0.87 04/30/2020 M 325,000 11/23/2015 11/23/2025 Common Stock 325,000 $ 0 0 D
Employee Stock Option $ 0.75 04/30/2020 M 152,000 01/04/2016 01/04/2026 Common Stock 152,000 $ 0 0 D
Employee Stock Option $ 1.09 04/30/2020 M 600,000 06/01/2019 06/01/2026 Common Stock 600,000 $ 0 0 D
Employee Stock Option $ 0.57 04/30/2020 M 199,800 06/01/2019 06/01/2027 Common Stock 199,800 $ 0 100,200 ( 4 ) D
Employee Stock Option $ 0.9 04/30/2020 M 50,000 06/18/2019 06/18/2029 Common Stock 50,000 $ 0 0 D
Employee Stock Option $ 0.8 04/30/2020 M 600,000 02/15/2018 02/15/2023 Common Stock 600,000 $ 0 0 D
Employee Stock Option $ 0.49 04/30/2020 M 116,550 06/08/2019 06/08/2028 Common Stock 116,550 $ 0 233,450 ( 5 ) D
Employee Stock Option $ 0.565 04/30/2020 M 1,000,000 04/08/2019 11/08/2028 Common Stock 1,000,000 $ 0 0 D
Employee Stock Option $ 0.39 04/30/2020 M 187,817 04/07/2019 10/07/2029 Common Stock 187,817 $ 0 187,183 ( 6 ) D
Employee Stock Option $ 0.63 04/30/2020 M 2,000,000 12/19/2019 12/19/2029 Common Stock 2,000,000 $ 0 0 D
Employee Stock Option $ 0.39 05/04/2020 M 30,933 10/07/2019 10/07/2029 Common Stock 30,933 $ 0 156,250 ( 6 ) D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Pourhassan Nader
1111 MAIN STREET, SUITE 660
VANCOUVER, WA98660
X President & CEO
Signatures
Arian Colachis, Attorney-in-fact 05/04/2020
Signature of Reporting Person Date
Explanation of Responses:
( 1 )This transaction was executed in multiple trades at prices ranging from $3.44 to $3.74. The price above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
( 2 )This transaction was executed in multiple trades at prices ranging from $3.13 to $3.54. The price above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
( 3 )This transaction was executed in multiple trades at prices ranging from $2.53 to $3.00. The price above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
( 4 )Option grant vests over a three year period beginning June 1, 2018.
( 5 )Option grant vests over a three year period beginning June 8, 2019.
( 6 )Option grant vests in equal monthly installments over a 12-month period beginning October 7, 2019.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.